Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

339 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The effect of adjuvant 5'-deoxy-5-fluorouridine in early stage breast cancer patients: results from a multicenter randomized controlled trial.
Tominaga T, Toi M, Abe O, Ohashi Y, Uchino J, Hayasaka H, Abe R, Izuo M, Enomoto K, Watanabe H, Yoshida M, Taguchi T, Koyama H, Senoo T, Toge T, Monden Y, Hattori T, Nomura Y, Sugimachi K, Hirata K, Nakazato H, Miura S, Morimoto T, Asaishi K, Kimijima I, Ota J, Sonoo H, Yamaguchi S; 5'-BC Study Group (5'-DFUR Adjuvant Chemotherapy for Breast Cancer Study Group). Tominaga T, et al. Among authors: toge t. Int J Oncol. 2002 Mar;20(3):517-25. Int J Oncol. 2002. PMID: 11836563 Clinical Trial.
Randomized controlled trial comparing oral doxifluridine plus oral cyclophosphamide with doxifluridine alone in women with node-positive breast cancer after primary surgery.
Tominaga T, Koyama H, Toge T, Miura S, Sugimachi K, Yamaguchi S, Hirata K, Monden Y, Nomura Y, Toi M, Kimijima I, Noguchi S, Sonoo H, Asaishi K, Ikeda T, Morimoto T, Ota J, Ohashi Y, Abe O. Tominaga T, et al. Among authors: toge t. J Clin Oncol. 2003 Mar 15;21(6):991-8. doi: 10.1200/JCO.2003.06.014. J Clin Oncol. 2003. PMID: 12637462 Clinical Trial.
Postoperative adjuvant randomised trial comparing chemoendocrine therapy, chemotherapy and immunotherapy for patients with stage II breast cancer: 5-year results from the Nishinihon Cooperative Study Group of Adjuvant Chemoendocrine Therapy for Breast Cancer (ACETBC) of Japan.
Morimoto T, Ogawa M, Orita K, Sugimachi K, Toge T, Dohi K, Nomura Y, Monden Y, Ogawa N. Morimoto T, et al. Among authors: toge t. Eur J Cancer. 1996 Feb;32A(2):235-42. doi: 10.1016/0959-8049(95)00579-x. Eur J Cancer. 1996. PMID: 8664034 Clinical Trial.
Postoperative chemo-endocrine treatment with mitomycin C, tamoxifen, and UFT is effective for patients with premenopausal estrogen receptor-positive stage II breast cancer. Nishinihon Cooperative Study Group of Adjuvant Therapy for Breast Cancer.
Sugimachi K, Maehara Y, Akazawa K, Nomura Y, Eida K, Ogawa M, Konaga E, Tanaka N, Toge T, Dohi K, Noda S, Maeda M, Monden Y. Sugimachi K, et al. Among authors: toge t. Breast Cancer Res Treat. 1999 Jul;56(2):113-24. doi: 10.1023/a:1006221425652. Breast Cancer Res Treat. 1999. PMID: 10573104 Clinical Trial.
[Late phase II clinical study of KW-2307 in advanced/recurrent breast cancer patients (II)].
Tominaga T, Nomura Y, Horikoshi N, Takashima S, Kimura M, Koyama H, Kikkawa N, Toge T, Mitsuyama S, Morimoto T, Enomoto K, Wada T, Kimishima I, Niitani H; KW-2307 Cooperative Study Group (Breast Cancer Section). Tominaga T, et al. Among authors: toge t. Gan To Kagaku Ryoho. 2005 Jul;32(7):983-90. Gan To Kagaku Ryoho. 2005. PMID: 16044960 Clinical Trial. Japanese.
339 results